{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:01Z","timestamp":1790661061645,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s00213-007-0937-2","type":"journal-article","created":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T19:58:21Z","timestamp":1190836701000},"page":"105-116","source":"Crossref","is-referenced-by-count":66,"title":["Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers"],"prefix":"10.1007","volume":"196","author":[{"given":"James P.","family":"Zacny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Lichtor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,27]]},"reference":[{"key":"937_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and statistical manual of mental disorders DSM-IV-TR (Text Revision)","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders DSM-IV-TR (Text Revision). American Psychiatric Association, Washington DC"},{"key":"937_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3758\/BF03331551","volume":"10","author":"AD Baddeley","year":"1968","unstructured":"Baddeley AD (1968) A three-minute reasoning test based on grammatical transformation. Psychon Sci 10:341\u2013342","journal-title":"Psychon Sci"},{"key":"937_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","volume":"12","author":"PM Beardsley","year":"2004","unstructured":"Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS (2004) Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Exp Clin Psychopharmacol 12:163\u2013172","journal-title":"Exp Clin Psychopharmacol"},{"key":"937_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0885-3924(96)00300-4","volume":"13","author":"DP Benziger","year":"1997","unstructured":"Benziger DP, Miotto J, Grandy RP, Thomas GB, Swanton RE, Fitzmartin RD (1997) A pharmacokinetic\/pharmacodynamic study of controlled-release oxycodone. J Pain Symptom Manage 13:75\u201382","journal-title":"J Pain Symptom Manage"},{"key":"937_CR5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1360-0443.1991.tb01756.x","volume":"86","author":"GE Bigelow","year":"1991","unstructured":"Bigelow GE (1991) Human drug abuse liability assessment: opioids and analgesics. Br J Addict 86:1615\u20131628","journal-title":"Br J Addict"},{"key":"937_CR6","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","volume":"16","author":"E Bruera","year":"1998","unstructured":"Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I (1998) Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 16:3222\u20133229","journal-title":"J Clin Oncol"},{"key":"937_CR7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","volume":"6","author":"TJ Cicero","year":"2005","unstructured":"Cicero TJ, Inciardi JA, Munoz A (2005) Trends in abuse of OxyContin\u00ae and other opioid analgesics in the United States: 2002\u20132004. J Pain 6:662\u2013672","journal-title":"J Pain"},{"key":"937_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","volume":"16","author":"SL Collins","year":"1998","unstructured":"Collins SL, Faura CC, Moore RA, McQuay HJ (1998) Peak plasma concentrations after oral morphine: a systematic review. J Pain Symptom Manage 16:388\u2013402","journal-title":"J Pain Symptom Manage"},{"key":"937_CR9","unstructured":"Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2007) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology e-pub, accessed September 14, 2007"},{"key":"937_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"WM Compton","year":"2006","unstructured":"Compton WM, Volkow ND (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81:103\u2013107","journal-title":"Drug Alcohol Depend"},{"key":"937_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002280050651","volume":"55","author":"GB Curtis","year":"1999","unstructured":"Curtis GB, Johnson GH, Clark P, Taylor R, Brown J, O'Callaghan R, Shi M, Lacouture PG (1999) Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 55:425\u2013429","journal-title":"Eur J Clin Pharmacol"},{"key":"937_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2005.08.019","volume":"82","author":"N Dasgupta","year":"2006","unstructured":"Dasgupta N, Kramer ED, Zalman M-A, Carino S Jr, Smith MY, Haddox JD, Wright C 4th (2006) Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 82:135\u2013142","journal-title":"Drug Alcohol Depend"},{"key":"937_CR13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3565(24)38221-7","volume":"289","author":"T Eissenberg","year":"1999","unstructured":"Eissenberg T, Stitzer ML, Bigelow GE, Buchhalter AR, Walsh SL (1999) Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions. J Pharmacol Exp Ther 289:936\u2013945","journal-title":"J Pharmacol Exp Ther"},{"key":"937_CR14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jps.2600731047","volume":"73","author":"IL Fedder","year":"1984","unstructured":"Fedder IL, Vlasses PH, Mojaverian P, Rocci ML Jr, Rotmensch HH, Swanson BN, Ferguson RK (1984) Relationship of morphine-induced miosis to plasma concentration in normal subjects. J Pharm Sci 73:1496\u20131497","journal-title":"J Pharm Sci"},{"key":"937_CR15","volume-title":"Statistical method in biological assay","author":"DJ Finney","year":"1964","unstructured":"Finney DJ (1964) Statistical method in biological assay. Hafner, New York"},{"key":"937_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM198507113130205","volume":"313","author":"KM Foley","year":"1985","unstructured":"Foley KM (1985) The treatment of cancer pain. N Engl J Med 313:84\u201395","journal-title":"N Engl J Med"},{"key":"937_CR17","first-page":"443","volume":"98","author":"HF Fraser","year":"1954","unstructured":"Fraser HF, Nash TL, Vanhorn GD, Isbell H (1954) Use of miotic effect in evaluating analgesic drugs in man. Arch Int Pharmacodyn Ther 98:443\u2013451","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"937_CR18","first-page":"371","volume":"133","author":"HF Fraser","year":"1961","unstructured":"Fraser HF, van Horn GD, Martin WR, Wolbach AB, Isbell H (1961) Methods for evaluating addiction liability. (a) \u201cattitude\u201d of opiate addicts toward opiate-like drugs, (b) a short-term \u201cdirect\u201d addiction test. J Pharmacol Exp Ther 133:371\u2013387","journal-title":"J Pharmacol Exp Ther"},{"key":"937_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpainsymman.2004.01.003","volume":"28","author":"AM Gilson","year":"2004","unstructured":"Gilson AM, Ryan KM, Joranson DE, Dahl JL (2004) A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997\u20132002. J Pain Symptom Manage 28:176\u2013188","journal-title":"J Pain Symptom Manage"},{"key":"937_CR20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.1993.11.5.973","volume":"11","author":"PA Glare","year":"1993","unstructured":"Glare PA, Walsh TD (1993) Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol 11:973\u2013978","journal-title":"J Clin Oncol"},{"key":"937_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR II, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4:3\u201313","journal-title":"Behav Pharmacol"},{"key":"937_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2466\/pr0.1966.18.1.163","volume":"18","author":"CA Haertzen","year":"1966","unstructured":"Haertzen CA (1966) Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol Rep 18:163\u2013194","journal-title":"Psychol Rep"},{"key":"937_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587\u2013593","journal-title":"Br J Cancer"},{"key":"937_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","volume":"73","author":"T Heiskanen","year":"1997","unstructured":"Heiskanen T, Kalso E (1997) Controlled-release oxycodone and morphine in cancer related pain. Pain 73:37\u201345","journal-title":"Pain"},{"key":"937_CR25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","volume":"39","author":"TE Heiskanen","year":"2000","unstructured":"Heiskanen TE, Ruismaki PM, Seppala TA, Kalso EA (2000) Morphine or oxycodone in cancer pain. Acta Oncol 39:941\u2013947","journal-title":"Acta Oncol"},{"key":"937_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-642-66612-4_4","volume-title":"Drug addiction I","author":"DR Jasinski","year":"1977","unstructured":"Jasinski DR (1977) Assessment of the abuse potential of morphine-like drugs (methods used in man). In: Martin WR (ed) Drug addiction I. Springer-Verlag, Berlin, pp 197\u2013258"},{"key":"937_CR27","volume-title":"Monitoring the Future national results on adolescent drug use: overview of key findings, 2006. (NIH Publication No. 07\u20136202)","author":"LD Johnston","year":"2007","unstructured":"Johnston LD, O\u2019Malley PM, Bachman JG, Schulenberg JE (2007) Monitoring the Future national results on adolescent drug use: overview of key findings, 2006. (NIH Publication No. 07\u20136202). National Institute on Drug Abuse, Bethesda, MD"},{"key":"937_CR28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","volume":"47","author":"E Kalso","year":"1990","unstructured":"Kalso E, Vainio A (1990) Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 47:639\u2013646","journal-title":"Clin Pharmacol Ther"},{"key":"937_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ajp.0000210953.86255.8f","volume":"23","author":"NP Katz","year":"2007","unstructured":"Katz NP, Adams EH, Benneyan JC, Birnbaum HG, Budman SH, Buzzeo RW, Carr DB, Cicero TJ, Gourlay D, Inciardi JA, Joranson DE, Kesslick J, Lande SD (2007) Foundations of opioid risk management. Clin J Pain 23:103\u2013118","journal-title":"Clin J Pain"},{"key":"937_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","volume":"79","author":"B Lalovic","year":"2006","unstructured":"Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD (2006) Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy subjects: role of circulating active metabolites. Clin Pharmacol Ther 79:461\u2013479","journal-title":"Clin Pharmacol Ther"},{"key":"937_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00000542-200610000-00027","volume":"105","author":"KK Lemberg","year":"2007","unstructured":"Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER, Kalso EA (2007) Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats. Anesthesiology 105:801\u2013812","journal-title":"Anesthesiology"},{"key":"937_CR32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM199610103351507","volume":"335","author":"MH Levy","year":"1996","unstructured":"Levy MH (1996) Pharmacologic treatment of cancer pain. N Engl J Med 335:1124\u20131132","journal-title":"N Engl J Med"},{"key":"937_CR33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2125.1996.00481.x","volume":"42","author":"JW Mandema","year":"1996","unstructured":"Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR (1996) Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Pharmacol 42:747\u2013756","journal-title":"Br J Pharmacol"},{"key":"937_CR34","first-page":"283","volume":"35","author":"WR Martin","year":"1984","unstructured":"Martin WR (1984) Pharmacology of opioids. Pharmacol Rev 35:283\u2013323","journal-title":"Pharmacol Rev"},{"key":"937_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"937_CR36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","volume":"2","author":"P Mucci-LoRusso","year":"1998","unstructured":"Mucci-LoRusso P, Berman BS, Silberstein PT, Citron ML, Bressler L, Weinstein SM, Kaiko RF, Buckley BJ, Reder RF (1998) Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 2:239\u2013249","journal-title":"Eur J Pain"},{"key":"937_CR37","first-page":"91","volume":"295","author":"CK Nielsen","year":"2000","unstructured":"Nielsen CK, Ross FB, Smith MT (2000) Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat. J Pharmacol Exp Ther 295: 91\u201399","journal-title":"J Pharmacol Exp Ther"},{"key":"937_CR38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0773.1991.tb01253.x","volume":"68","author":"EJ Nuotto","year":"1991","unstructured":"Nuotto EJ, Korttila K (1991) Evaluation of a new computerized psychomotor test battery: effects of alcohol. Pharmacol Toxicol 68:360\u2013365","journal-title":"Pharmacol Toxicol"},{"key":"937_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5055\/jom.2006.0020","volume":"2","author":"SD Passik","year":"2006","unstructured":"Passik SD, Heit H, Kirsh KL (2006) Reality and responsibility: a commentary on the treatment of pain and suffering in a drug-using society. J Opioid Manag 2:123\u2013127","journal-title":"J Opioid Manag"},{"key":"937_CR40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0376-8716(98)00026-X","volume":"50","author":"NM Petry","year":"1998","unstructured":"Petry NM, Bickel WK, Huddleston J, Tzanis E, Badger GJ (1998) A comparison of subjective, psychomotor and physiological effects of a novel muscarinic analgesic, LY297802 tartrate, and oral morphine in occasional drug users. Drug Alcohol Depend 50: 129\u2013136","journal-title":"Drug Alcohol Depend"},{"key":"937_CR41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","volume":"33","author":"R Poyhia","year":"1992","unstructured":"Poyhia R, Seppala T, Olkkola KT, Kalso E (1992) The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol 33: 617\u2013621","journal-title":"Br J Clin Pharmacol"},{"key":"937_CR42","first-page":"184","volume":"250","author":"KL Preston","year":"1989","unstructured":"Preston KL, Bigelow GE, Bickel WK, Liebson IA (1989) Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 250:184\u2013196","journal-title":"J Pharmacol Exp Ther"},{"key":"937_CR43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.166.8.837","volume":"166","author":"CM Reid","year":"2006","unstructured":"Reid CM, Martin RM, Sterne JAC, Davies AN, Hanks GW (2006) Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 166:837\u2013843","journal-title":"Arch Intern Med"},{"key":"937_CR44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(97)00093-6","volume":"73","author":"FB Ross","year":"1997","unstructured":"Ross FB, Smith MT (1997) The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 73:151\u2013157","journal-title":"Pain"},{"key":"937_CR45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0304-3959(99)00230-4","volume":"84","author":"FB Ross","year":"2000","unstructured":"Ross FB, Wallis SC, Smith MT (2000) Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 84:421\u2013428","journal-title":"Pain"},{"key":"937_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pain.2006.02.006","volume":"123","author":"C Staahl","year":"2006","unstructured":"Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM (2006) A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 123:28\u201336","journal-title":"Pain"},{"key":"937_CR47","unstructured":"Substance Abuse and Mental Health Services Administration (2006a) Results from the 2005 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. (SMA) 06\u20134194). Rockville, MD"},{"key":"937_CR48","unstructured":"Substance Abuse and Mental Health Services Administration (2006b) Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. (Office of Applied Studies, DAWN Series D-28, DHHS Publication No. (SMA) 06\u20134143). Rockville, MD"},{"key":"937_CR49","unstructured":"Substance Abuse and Mental Health Services Administration (2006c) Treatment Episode Data Set (TEDS). Highlights \u2013 2005. National Admissions to Substance Abuse Treatment Services. (Office of Applied Studies, DASIS Series S-36, DHHS Publication No. (SMA) 07\u20134229). Rockville, MD"},{"key":"937_CR50","unstructured":"Substance Abuse and Mental Health Services Administration (2006d) 2005 National Survey on Drug Use & Health Detail Tables: http:\/\/www.oas.samhsa.gov\/NSDUH\/2k5nsduh\/tabs\/Sect1peTabs128to132.pdf (accessed July 3, 2007)"},{"key":"937_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0376-8716(03)00172-8","volume":"72","author":"M Tancer","year":"2003","unstructured":"Tancer M, Johanson CE (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72:33\u201344","journal-title":"Drug Alcohol Depend"},{"key":"937_CR52","doi-asserted-by":"crossref","DOI":"10.1037\/11167-000","volume-title":"The measurement and appraisal of adult intelligence","author":"D Wechsler","year":"1958","unstructured":"Wechsler D (1958) The measurement and appraisal of adult intelligence. Williams and Wilkins, Baltimore"},{"key":"937_CR53","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.298.6682.1222","volume":"298","author":"ID White","year":"1989","unstructured":"White ID, Hoskin PJ, Hanks GW, Bliss JM (1989) Morphine and dryness of mouth. Brit Med J 298:1222\u20131223","journal-title":"Brit Med J"},{"key":"937_CR54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1540-9","volume":"170","author":"JP Zacny","year":"2003","unstructured":"Zacny JP, Gutierrez S (2003) Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl) 170:242\u2013254","journal-title":"Psychopharmacology (Berl)"},{"key":"937_CR55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","volume":"69","author":"J Zacny","year":"2003","unstructured":"Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C (2003) College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 69:215\u2013232","journal-title":"Drug Alcohol Depend"},{"key":"937_CR56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drugalcdep.2004.11.009","volume":"78","author":"JP Zacny","year":"2005","unstructured":"Zacny JP, Gutierrez S, Bolbolan SA (2005) Profiling the subjective, psychomotor, and physiological effects of a hydrocodone\/acetaminophen product in recreational drug users. Drug Alcohol Depend 78:243\u2013252","journal-title":"Drug Alcohol Depend"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-007-0937-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0937-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:04:17Z","timestamp":1737439457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-007-0937-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0937-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,27]]}}}